-+ 0.00%
-+ 0.00%
-+ 0.00%

Xunfei Healthcare Clarifies Basis for Beijing Huiji’s RMB 300 Million Pre-Investment Valuation

PUBT·11/12/2026 12:46:26
Listen to the news
Xunfei Healthcare Clarifies Basis for Beijing Huiji’s RMB 300 Million Pre-Investment Valuation
  • Xunfei Healthcare clarified on November 12, 2026, that Beijing Huiji’s pre-investment valuation was set at RMB 300 million.
  • iFlytek Yunchuang will invest RMB 32 million for a 9.64% stake in Beijing Huiji following the capital increase.
  • The valuation implies a price-to-sales ratio of approximately 8.57 times, broadly matching the comparable group’s average of 8.38 times.
  • Average operating revenue of RMB 35 million over the past two years underpinned the valuation; Beijing Huiji remains unprofitable.
  • The board considers the capital increase pricing fair and reasonable.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xunfei Healthcare Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261112-12410374), on November 12, 2026, and is solely responsible for the information contained therein.